Can delta-8 THC cause a positive employment drug test? What tests look for, how employers handle it, and the 2026 federal hemp changes
On this page
- What is delta-8 THC?
- What do employment drug tests look for?
- How is a delta-8 explanation handled in a DOT test?
- What may non-DOT employers do with a THC positive blamed on delta-8?
- What changed in federal hemp law in 2026?
- What should employers tell candidates about delta-8?
- Checklist for delta-8 questions in hiring
- Questions people ask
Yes, delta-8 THC can lead to a positive employment drug test, even though workplace tests do not name it: federal panels look for delta-9 THC (in urine, its carboxylic acid metabolite), and FDA warns that delta-8 products vary in formulation and labeling, contain other cannabinoids, and are usually made by chemically converting CBD. A result the laboratory confirms as marijuana is treated as marijuana whatever the candidate says caused it, and in DOT testing the Medical Review Officer (MRO) may not accept a hemp product as an explanation. The federal hemp definition changed in November 2026, which affects what may be sold, not what a test detects, as of November 2026.
CBD raises a similar question with different facts; it has its own page: CBD and pre-employment drug tests. State rules on off-duty cannabis use are on marijuana drug testing laws by state.
Not legal advice. This page summarizes 49 CFR Part 40 on eCFR, HHS's federal drug testing panel notice, FDA's delta-8 consumer update, DEA's 2020 hemp rule and Public Laws 119-37 and 119-103 on govinfo, checked as of November 2026. Federal hemp law has changed twice in a year; check the current text before relying on any date.
What is delta-8 THC?
FDA's consumer update, 5 Things to Know about Delta-8 THC, describes it as a psychoactive substance found in the Cannabis sativa plant, one of over 100 cannabinoids the plant produces but not present in significant amounts, so concentrated delta-8 is typically manufactured from hemp-derived CBD. FDA says delta-8 products have not been evaluated or approved by FDA for safe use, have psychoactive and intoxicating effects similar to delta-9 THC, and may be labeled simply as "hemp products," and it lists concerns about variable formulations, labeling, other cannabinoid content and contaminants from the chemical conversion.
What do employment drug tests look for?
| Testing program | Specimen | Marijuana analyte | Source |
|---|---|---|---|
| DOT | Urine | Marijuana metabolites (THCA), 50 ng/mL screen, 15 ng/mL confirmation | 49 CFR 40.85 |
| DOT | Oral fluid (authorized, but no HHS-certified oral fluid laboratory yet) | THC, 4 ng/mL screen, 2 ng/mL confirmation | 49 CFR 40.91 |
| Federal agency (HHS) | Urine | Delta-9-tetrahydrocannabinol-9-carboxylic acid | 91 FR 12308 (Mar. 13, 2026) |
| Federal agency (HHS) | Oral fluid | Delta-9-tetrahydrocannabinol | Same notice |
| Company (non-DOT) | Set by employer and laboratory | Ask the laboratory | 5-panel vs 10-panel tests |
No federal panel lists delta-8 THC, and DOT laboratories may test DOT specimens only for the five drug classes in 40.82. That leaves two ways a delta-8 user ends up with a marijuana result:
- Delta-9 THC in the product. Hemp products may legally contain some delta-9 THC: under the 2018 definition, plant material with 0.3 percent or less delta-9 THC by dry weight was not controlled, as DEA's 2020 rule explains (85 FR 51639). FDA's warnings about variable formulations and other cannabinoid content mean a candidate cannot know what a product delivered.
- The laboratory's methods. Screening immunoassays are calibrated to a target analyte (40.85, note 2), and whether delta-8 metabolites trigger a particular screen, and whether the confirmation method separates them from the delta-9 metabolite, depends on the assay and the method. Ask your laboratory in writing; do not rely on general claims either way.
How is a delta-8 explanation handled in a DOT test?
The same way as CBD. After a laboratory-confirmed marijuana positive the MRO offers the candidate an interview, but under 40.151(f) the MRO "must not accept an assertion of consumption or other use of a hemp or other non-prescription marijuana-related product" as a basis for verifying the test negative, and a physician's recommendation under a state law is not a medical explanation either (40.151(e)). The test is verified positive, and:
- the candidate may not perform safety-sensitive work for any DOT employer until completing the SAP and return-to-duty process, and you give them a list of Substance Abuse Professionals;
- for CDL drivers the MRO reports the verified positive to the FMCSA Clearinghouse within two business days (382.705(a));
- the April 28, 2026 order moving FDA-approved marijuana drug products and state-licensed medical marijuana to Schedule III (91 FR 22714) applies to marijuana outside the definition of hemp only when it is in an FDA-approved drug or under a state medical marijuana license, so it does not cover delta-8 products sold as hemp.
HHS applies the same rule to federal agency testing: its November 13, 2025 memo to federal MROs says the only legitimate medical explanation for a marijuana positive is a verified prescription for an FDA-approved cannabis-derived or synthetic cannabis-related drug, such as Marinol or Syndros. The next steps after a verified positive are in what to do when a candidate fails a pre-employment drug test.
What may non-DOT employers do with a THC positive blamed on delta-8?
- Treat it as the laboratory reports it. A confirmed marijuana positive is a marijuana positive. Route explanations to the MRO; a prescription for an FDA-approved drug is different from a store-bought product (prescription medications and drug tests).
- Check the state law where the person will work. Several states limit testing for cannabis or action on a positive result; whether a state's protection reaches hemp-derived THC depends on how its statute defines cannabis, so read the statute rather than assuming. The state-by-state table is on marijuana drug testing laws by state.
- Apply your written policy the same way to everyone. If the policy treats a verified THC positive as disqualifying for the job, apply it whatever source the candidate names; if it does not, do not make an exception for one candidate. The drug testing policy template shows how to name hemp-derived THC products explicitly.
- Do not rest the decision on the product's legal status. That status is changing (below), DEA has said since 2020 that all synthetically derived tetrahydrocannabinols remain Schedule I (85 FR 51639), and whether a specific product was lawful is not something a hiring team can settle. Policy and state law are what the decision should rest on.
What changed in federal hemp law in 2026?
Section 781 of Public Law 119-37, enacted November 12, 2025, rewrote the definition of hemp in 7 U.S.C. 1639o effective 365 days after enactment, that is, November 12, 2026. The new text:
- measures hemp by total tetrahydrocannabinols, including tetrahydrocannabinolic acid, at no more than 0.3 percent on a dry weight basis;
- excludes intermediate and final hemp-derived cannabinoid products that contain cannabinoids the plant cannot naturally produce, or cannabinoids the plant can produce but that "were synthesized or manufactured outside the plant";
- excludes final products with more than 0.4 milligrams per container of total THC combined with other cannabinoids that have, or are marketed as having, similar effects, as determined by HHS;
- directed FDA to publish, within 90 days, lists of cannabinoids the plant can naturally produce and of cannabinoids with THC-like effects.
Section 2019 of Public Law 119-103, signed September 2, 2026, then provides that until December 11, 2026 the amendments apply only to products containing cannabinoids "not capable of being naturally produced" by the plant. Read alongside FDA's description of delta-8 as typically made by converting CBD, the categories that matter most for delta-8 products are the "synthesized or manufactured outside the plant" exclusion and the per-container limit, which Public Law 119-103 holds back until December 11, 2026 unless Congress acts again. For employers, three points hold whatever happens to those dates: a drug test reports what is in the specimen, not whether the product was legal; DOT does not accept hemp products as an explanation (40.151(f)); and state cannabis protections, not federal hemp law, decide most non-DOT cases.
What should employers tell candidates about delta-8?
Say it before the test, in the testing instructions. An example to adapt to your policy and state law:
Example (review with counsel before use): Our drug test looks for THC. Delta-8 THC, CBD and other hemp products can contain THC, they are not FDA-approved, and their labels may not show what is in them, so using them can lead to a positive result for marijuana. [For positions regulated by the U.S. Department of Transportation, use of hemp products is not accepted as an explanation for a positive result.] Questions about products or medications go to the Medical Review Officer, not to the hiring team.
Checklist for delta-8 questions in hiring
- Ask your laboratory which marijuana analytes it screens for and confirms, and how its methods treat delta-8 metabolites.
- Name delta-8 and other hemp-derived THC products in your policy and testing instructions.
- Send every positive through an MRO; recruiters should not discuss products or medications with candidates.
- For DOT jobs, treat a verified THC positive as a DOT violation regardless of the claimed source.
- For other jobs, check the state statute where the person will work before acting, and apply the policy consistently.
- Record the verified result and the decision in the drug testing file, kept apart from interview notes.
Questions people ask
Will delta-8 THC show up on a drug test for a job?
It can show up as a marijuana positive. Federal workplace panels look for delta-9 THC (in urine, its carboxylic acid metabolite), not delta-8 by name, but FDA warns that delta-8 products vary in formulation and labeling and contain other cannabinoids, and any delta-9 THC in a product produces the same result as marijuana. Whether delta-8 alone triggers a given laboratory's screen depends on its methods, so ask the laboratory.
Is delta-8 use an acceptable explanation for a positive DOT drug test?
No. Under 49 CFR 40.151(f), a Medical Review Officer must not accept an assertion of consumption or use of a hemp or other non-prescription marijuana-related product as a basis for verifying a marijuana test negative. A laboratory-confirmed marijuana positive blamed on delta-8 is verified positive, with all DOT consequences, as of November 2026.
Did the 2026 federal hemp law make delta-8 products illegal?
The law changed the definition of hemp on November 12, 2026 (Public Law 119-37, section 781), excluding products with cannabinoids synthesized outside the plant and final products with more than 0.4 milligrams of total THC and similar cannabinoids per container. Public Law 119-103 then limited the change until December 11, 2026 to products with cannabinoids the plant cannot naturally produce. Whether a particular product is lawful is for regulators and courts; it does not change what a drug test finds.
Can an employer refuse to hire someone who tested positive after using delta-8?
For DOT jobs, the verified positive has DOT consequences whatever the source. For other jobs, the employer treats it as a marijuana positive under its written policy and the law of the state where the person will work; some states limit action on cannabis results, and how their statutes treat hemp-derived THC differs, so check the state's statute before acting.
Do employment drug tests test specifically for delta-8 THC?
The federal panels do not: DOT and HHS name delta-9 THC compounds as the marijuana analytes (49 CFR 40.85 and HHS's March 13, 2026 panel notice), and DOT laboratories may not test DOT specimens for anything else. Non-DOT panels are set by the laboratory and employer, so ask your laboratory which marijuana analytes it screens and confirms.